Evidence map›Paper›PMID 40966506›Full record

ArticleNucleic acids research2025

Phosphorylation of H3.3 at Serine 31 acts as a switch of nucleosome dynamics for transcription.

Jingzhe Ma, Junran Zhang, Xue Xiao, Li Gao, Hang Zhou, Dengyu Ji, Ying Zhang, Guohong Li, Juan Yu, Ping Chen and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jingzhe MaDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Junran ZhangDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Xue XiaoState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Li GaoDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Hang ZhouDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Dengyu JiDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Ying ZhangDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Guohong LiState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0003-2137-0783
Juan YuState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Ping ChenDepartment of Immunology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.ORCID 0000-0003-0295-0846
Wei LiState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-2493-1083

Funding

CAS JZHKYPT-2021-05Central Universities 2042022dx0003Chinese Academy of Sciences XDB37000000Ministry of Science and Technology 2022YFA0912400Ministry of Science and Technology 2023YFA0913400National Natural Science Foundation of China 21991133National Natural Science Foundation of China 31991161National Natural Science Foundation of China 32230020National Natural Science Foundation of China 32370573National Natural Science Foundation of China 32370645New Cornerstone Science Foundation
6 · The paper itself

Abstract

The incorporation of histone variant H3.3 into the genome plays a critical role in regulating gene transcription, genomic stability, and mitosis progression. However, the precise mechanisms underlying the influence of H3.3 on nucleosome stability and dynamics remain poorly understood. In this study, we demonstrate that while the incorporation of H3.3 into nucleosomes does not significantly alter their stability, it enhances the maintenance of nucleosome integrity. Notably, H3.3 recruits the FACT complexes more efficiently than the canonical H3, counteracting FACT's destabilizing effect on nucleosomes. The binding of FACT to H3.3-nucleosome further stabilizes the nucleosome structure, which can be reversed by phosphorylation at Serine 31 (H3.3S31ph). Through genome-wide analyses, we show that the deposition of H3.3 and its phosphorylation at Ser31 dynamically modulate the nucleosome states, influencing FACT binding and regulating the transcriptional responses in macrophages upon stimulation. The selective phosphorylation at H3.3S31 functions as a pivotal switch, transforming the H3.3-nucleosome from a stable, maintenance-oriented state to a more dynamic, active configuration. This molecular switch enables a rapid response to environmental stimuli, thereby facilitating transcriptional activation. Our findings provide new mechanistic insights into how H3.3 and its Ser31 phosphorylation modulate nucleosome dynamics and transcriptional response, with significant implications for immune response pathways in macrophages.

Indexed as

HistonesNucleosomesSerineTranscription, GeneticAnimalsHumansMacrophagesMicePhosphorylationTranscriptional ActivationTranscriptional Elongation FactorsHistonesNucleosomesSerineTranscriptional Elongation Factors

Identifiers

PMID40966506
PMCPMC12445699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.